Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...

The Morning Bull - US Market Morning Update Friday, Jul, 3 2026 US stock futures are slightly weaker this morning, with S&P ...

Thousands of articles have dissected the revolution we celebrate this week. Millions of words have been written about the ...

Some information you come across about COVID-19 may be out of date or false. Learn about COVID-19 myths so you can bust them when you see them.

Unicycive OLC received a second FDA CRL over third-party manufacturing deficiencies. The case shows why CMC risk now drives ...

CNBC's Jim Cramer said Moderna's expanding pipeline in treatments for cancer and other diseases provides a compelling ...

Health-care companies rose as traders continued to rotate out of high-risk artificial-intelligence stocks into lagging sectors. Shares of Moderna added to recent gains amid optimism the vaccine ...

Stocks are rising Thursday to end the shortened holiday trading week.

The human-made cells show many hallmarks of life, but they can't make all their necessary internal structures or divide for ...

Passive income is characterized by its ability to generate revenue without requiring the earner’s continuous active effort, ...